119 results
424B3
ELDN
Eledon Pharmaceuticals Inc
6 Jun 24
Prospectus supplement
4:01pm
applicable beneficial ownership limitation. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership … hereafter adopted by the SEC having substantially the same purpose and effect as such rule (“Rule 144”), or any other exemption from registration under
8-K
EX-4.1
ELDN
Eledon Pharmaceuticals Inc
7 May 24
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
7:15am
for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders … this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time
8-K
EX-10.2
ELDN
Eledon Pharmaceuticals Inc
7 May 24
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
7:15am
or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect … to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.
“Selling
8-K
EX-10.1
rshrca6pi6o1fmuy
7 May 24
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
7:15am
8-K
EX-10.1
s6ukmchpm
20 Sep 23
Departure of Directors or Certain Officers
7:09pm
S-8
hfene2eu8j2u4dbbh4e
10 Aug 23
Registration of securities for employees
6:28pm
S-8
86q5suu6lbbf73m x8
10 Aug 23
Registration of securities for employees
6:28pm
8-K
EX-10.1
m52b88an
21 Jun 23
Departure of Directors or Certain Officers
7:51pm
424B3
tkew9zyt341u07
8 Jun 23
Prospectus supplement
4:04pm
8-K
EX-10.1
2ixu4h55 uqkqrxc9rtu
1 May 23
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
7:27am
8-K
EX-4.2
s6ctxu3psz9jvj0v
1 May 23
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
7:27am
8-K
EX-10.2
bxxjof ifpwrb48gc
1 May 23
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
7:27am
8-K
EX-4.1
ps2uur nznfn3
1 May 23
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
7:27am